Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
it is bookmarked. watch TMXO
hello themuzicmen!
may i come on board? :)
good morning TTOON
TMXO!
UPDA!!
i told you this one last week
GLIF watch it
UCOI watch it
ACTC GOGOGO!!!
UDTT news today, chart looks pretty good...
UNIVERSAL DETECTION TECH
UDTT
Universal Detection Technology in Deal With Net Solutions to Enhance Internet Presence of Its Anthrax Detection System
9/21/2006
LOS ANGELES, Sept 21, 2006 /PRNewswire-FirstCall via COMTEX News Network/ --
Universal Detection Technology (www.udetection.com) (OTC Bulletin Board: UDTT; FWB: PO8), a developer of early-warning monitoring technologies to protect people from bio-terrorism and other infectious health threats, announced today that it has commenced enhancement of the company's web presence.
The company has signed a cooperation agreement with Net Solutions aimed at optimizing its website, enhancing content, and submitting its site to major search engines.
"We have seen that the vast majority of our company's sales leads are increasingly being generated from our presence on the world-wide-web, as well as articles and features on our Anthrax Detectors," said Jacques Tizabi, CEO of Universal Detection Technology. "For Example, we are the first result of a search on Google for the phrase 'Anthrax detection.' We expect that our collaboration with Net Solutions will increase our search engine ranking and will direct more traffic to our website where information about our bio-terrorism detection technologies and counter-terrorism services is offered. This is especially important in light of our recent sales of our anthrax detectors as we also approach the 5 year anniversary of the deadly anthrax terror attacks on our country," he added.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices. The Company on its own and with development partners is positioned it to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA has developed a bio-terror 'smoke' detector that detects certain bio-hazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
SOURCE Universal Detection Technology
Jacques Tizabi of Universal Detection Technology, +1-310-248-3655, jtizabi@udetection.com; or Andrew Hellman of CEOcast, Inc., +1-212-732-4300, for Universal Detection Technology http://www.prnewswire.com
Copyright (C) 2006 PR Newswire. All rights reserved.
hy rook
sorry, really don´t know.
better ask JJ or TOON
Form 8-K for DERMISONICS, INC
20-Sep-2006
Unregistered Sale of Equity Securities, Financial Statements and Exhibits
ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES.
On September 14, 2006, Dermisonics, Inc. (the "Company") sold 1,300,000 restricted shares of its common stock, par value $.001 (the "Share"), to Mercatus & Partners, LP ("Mercatus") for a purchase price of $.25 per share for total proceeds of $325,000. The $.25 per share price represented an $.11 per share premium over the closing price of $.14 per share on September 13, 2006. In connection with the sale of the shares, the Company also issued a common stock purchase warrant (the "Warrant") entitling Mercatus to purchase an additional 1,300,000 shares at an exercise price of $.25 per share. The Warrant expires on September 30, 2009. The Shares and the Warrants were issued pursuant to Regulation S promulgated under the Securities Act of 1933.
The proceeds of the sale of the shares will be used for general working capital purposes, including costs associated with the HPT-2 human pilot trial being conducted on the Company's U-Strip technology, a patented electronic system that uses a specialized form of ultrasound waves to enhance the delivery of drugs through the skin and into the bloodstream from a specially modified patch.
The agreement previously announced on March 22, 2006, which provided for the sale to Mercatus of 7,200,000 shares for $4,134,240 ($.57 per share) is being renegotiated due to the decline of the market value of the Company's stock from the original date of the agreement to September 14, 2006. However, there is no assurance that an agreement for additional financing will be reached.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits. Furnished pursuant to Items 2.02 and 7.01.
10.88 Warrant issued to Mercatus & Partners, LP dated September 14,
2006, expiring September 30, 2009 at an exercise price of $.25 per
share
hy JJ! can´t find the 8-k. could you please post it?
CYHD anybody in it???
great chart, was that a 7-times bottom at .0024? lol
resistance at .0034 and .0040
UPDA on the move!
SLWF NEWS AND DOUBLE BOTTOM!
UPDA !!!
XKEM on the move!
XKEM !
GNTA !
WOOW!!
WWAT (.20) Contracts to Build $446,250 Solar System
WORLDWATER & POWER CORP
WWAT
WorldWater & Power Contracts to Build $446,250 Solar System for The Center for Great Expectations
9/18/2006
Pennington, N.J., Sept. 18, 2006, Sep 18, 2006 (PRIMEZONE via COMTEX News Network) --
WorldWater & Power Corp. (OTCBB:WWAT), developer and marketer of proprietary high-horsepower solar systems, today announced the signing of a $446,250 contract with The Center for Great Expectations to build a roof-top solar power system for the Center's new facility under construction in Somerville, New Jersey.
Grants from the N.J. Clean Energy Program and N.J. Housing Mortgage Finance Agency will pay for 50% of the solar installation cost and The Center will earn Solar Renewable Energy Certificates (SCRE's) on a long-term basis. "We estimate that solar energy will provide close to 100% of the electrical needs of the facility," said Cassandra Kling, WorldWater's Director of Business Development for the Eastern U.S.
The new "green" building was designed by the Prisco Group of Hopewell, N.J., to the Leadership in Energy and Environmental Design (LEED) standard of the U.S. Green Building Council. Prisco also incorporated high-energy efficient design, and environmentally preferable building materials into the project. Scott Prisco, Principal at the Prisco Group, said, "We are honored to provide a new building that will allow The Center to provide a safe harbor and home to these homeless women and children."
The Center for Great Expectations serves homeless pregnant women between the ages of 13 and 40 and seeking treatment for the effects of alcohol or drug dependency, homelessness, domestic violence, and other emotional problems. Licensed through the N.J. Department of Human Services, Division of Youth and Family Services (DYFS) The Center is also a network provider for The Substance Abuse Initiative, part of the N.J. Department of Health and Senior Services. Peg Wright, President of the Center, said, "It is our goal to offer our residents the best environment we can, whether it is in the form of educational opportunities, a caring touch, or the air they breathe."
About WorldWater & Power Corp:
WorldWater & Power Corporation is a full-service, international solar electric engineering and water management company with unique, high-powered and patented solar technology that provides solutions to a broad spectrum of the world's electricity and water supply problems. For more information about WorldWater & Power Corp., visit the website at www.worldwater.com.
The WorldWater & Power Corporation logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1629
This news release was distributed by PrimeZone, www.primezone.com
SOURCE: WorldWater & Power Corp.
WorldWater & Power
Jessie Sullivan
(609) 818-0700 X20
JSullivan@worldwater.com
Mike Breslin Productions LLC
Press Contact:
Mike Breslin
(201) 652-1287
mbrez@aol.com
Lippert/Heilshorn & Associates, Inc.
Investor Contact:
Jody Burfening
Chris Witty
(212) 838-3777
cwitty@lhai.com
(C) 2006 PRIMEZONE, All rights reserved.
UPDA-Chart looks very good...
UPDA (.056) Landmark Completes Mobilization at Catlin Field
UNIVERSAL PROP DEV & ACQ
UPDA
Landmark Completes Mobilization at Catlin Field - Pace of Program to Increase - Ambient to Develop Plan for Canyon Creek
9/18/2006
JACKSBORO, Texas, Sep 18, 2006 (BUSINESS WIRE) --
Now that Landmark 4, LLC has completed its mobilization to UPDA's Catlin Oil and Gas Field in Jack County, Texas, Universal Property Development and Acquisition Corporation (OTCBB:UPDA) subsidiary, Ambient Wells Services, Inc., is preparing an expansive plan to pursue similar programs at the various oil and gas fields owned by another UPDA subsidiary, Canyon Creek Oil and Gas, Inc. Once this plan is complete, Ambient will have crews working in Canyon Creek's fields in Archer, Coleman and Palo Pinto Counties while Landmark continues its efforts on Catlin with a crew of 10 or more men and hundreds of thousands of dollars of equipment purchased specifically for this aggressive project.
"These projects demonstrate the application of our new business model, revised to utilize our own crews and management to complete the well service work," said Chris McCauley, UPDA Vice President. "As a result of previous disappointments, UPDA management re-visited its business plan and determined that its own efforts resulted in the successful acquisition of many promising properties but its reliance then on others to manage and direct the workover of those properties was not succeeding in the same fashion. Accordingly, we assembled a team of our own experts and established Ambient Wells Services, Inc. to manage the projects and ensure their successful completion. The programs on Catlin, Archer, Coleman and Palo Pinto are just the beginning of what we are confident is a business plan that will ultimately generate the production that we always believed these properties were capable of generating."
"Now that we are in a position, using Ambient and Landmark, to properly repair and rework these wells and pipelines using our own crews and competent contractors, we have every reason to anticipate steady progress and immediate success," said Ambient COO Gaby Damary. "As demonstrated by last week's return of 7 wells to production on Catlin, we will be moving forward from this point with great urgency. At the current pace, we expect to have the 64 Catlin wells and pipeline completed and producing within Landmark's 60 day bonus period and Ambient's crews will be well on their way to increasing and restoring the production from as many as 75 Canyon Creek wells. We look forward to the work ahead of us."
The continuing progress of this project will be reported by UPDA as it continues to update its website at: www.universalpropertydevelopment.com.
About UPDA
Universal Property Development and Acquisition Corporation (OTCBB:UPDA) focuses on the acquisition and development of proven oil and natural gas reserves and other energy opportunities through the creation of joint ventures with under-funded owners of mineral leases and cutting-edge technologies.
Statements contained in this press release that are not based upon current or historical fact are forward-looking in nature. Such forward-looking statements reflect the current views of management with respect to future events and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, or described pursuant to similar expressions.
SOURCE: Universal Property Development and Acquisition Corporation
Universal Property Development and Acquisition Corporation Bradford Moore, 561-630-2977 (Investor Relations) info@updac.com
Copyright Business Wire 2006
news
DIAAF
Diamant Film Corporation Begins National Sales and Marketing Campaign Targeting Distribution to Restaurants and Major Catering Houses Nationwide
9/15/2006
Company to Distribute Its Superior Food Wrap Products to Commercial Marketplace
TORONTO, Sep 15, 2006 (MARKET WIRE via COMTEX News Network) --
Diamant Art Corporation (OTCBB: DIAAF) is pleased to announce today that, through its wholly owned subsidiary, Diamant Film Inc., the company will begin to pursue distribution opportunities for its line of unparalleled food wrap products to the restaurant, catering, and manufacturing sectors. The announcement was made by Stefan Gudmundsson, CEO of Diamant Film Corporation.
Diamant Food Wrap is currently in the kitchens of fine dining restaurants and major catering houses, as well as chain restaurants from Florida to New York. Diamant Food Wrap is the world's first plasticizer-free stretch film based on polystyrene and the first food wrap that is both environmentally friendly and recyclable.
Larger venues, like Florida's Riverside Hotel (www.riversidehotel.com), Cafe Maxx (www.cafemaxx.com), and Magna Racing's (www.gulfstreampark.com) will be using Diamant's special food wrap products designed for high end commercial volume usage.
"We have spent considerable time perfecting our product line to accommodate the larger volumes needed in these venues. Additionally, we have further developed and perfected our product packaging to make usage in volume easier and with less waste or storage," said Mr. Gudmundsson.
Diamant Film Corporation will be featured on "YOUR MONIES WORTH" and company executives will be interviewed live on national radio, as well as on www.fortunemarket.net. Listeners can log in at 7pm (EST) to hear the show Monday through Friday. The show features smaller OTCBB companies and their overall plans, listener calls, and Q&A sessions. The show is broadcast on radio through the Beasley Broadcasting Network out of South Florida and through Los Angeles on the Fortune Market Financial Network.
About Diamant Film Corporation
Diamant Film Corporation, through its wholly owned subsidiary Diamant Film Inc., has secured the exclusive marketing and distribution rights in the United States, Territory of the People's Republic of China, Canada, Mexico and the Bahamas to Diamant(TM) film, a non-PVC food stretch film.
Diamant(TM) film is the world's first plasticizer-free stretch film based on polystyrene and the first food wrap film that is environmentally friendly and recyclable. Diamant(TM) film has recently received the ECO logo certified by the Environmental Choice (M) Program. The Environmental Choice (M) Program is North America's leading benchmark of environmentally responsible products and services. Diamant(TM) film has successfully met the criteria for both the environmental and performance standards.
Safe Harbor
This media release may contain forward-looking statements regarding but not limited to management, market potential, distributor success, market size, international sales, marketing, future events and performance of the Company which involve risks and uncertainties that could materially affect actual results. Investors should refer to documents that the Company has filed with the SEC for a description of certain factors that could cause actual results to vary from current expectations and the forward-looking statements contained in this media release.
For further information, please contact: Media Contact: BZCOM Communications Mike Garfinkel Mikeg@bzcom.com 818-865-9898 Investor Relations Contact: Taylor Capitol, Inc. Stephen Taylor Phone 973-351-3868 E-mail: stephtayl9@aol.com or visit our website at www.diamantfilm.com
SOURCE: Diamant Art Corporation
mailto:Mikeg@bzcom.com mailto:stephtayl9@aol.com http://www.diamantfilm.com
Copyright 2006 Market Wire, All rights reserved.
CPNE (1.06) Commerce Planet Surpasses 750,000 Member Milestone
9/14/2006
GOLETA, Calif., Sept 14, 2006 /PRNewswire-FirstCall via COMTEX News Network/ --
Commerce Planet, Inc. (OTC Bulletin Board: CPNE) today announced that it has surpassed the major milestone of over 750,000 paid members serviced.
Commerce Planet Chairman and CEO Michael Hill stated, "I am proud to announce that in just three short years, over 750,000 individuals at some point chose to become paying members of our offerings during that period. Early on, the original sales driver was our core offering onlinesupplier.com. Clearly our growth has accelerated with the additional successes of buydiscount.com and mysoftwaretutor.com. He added, "Now with the further additions of legacynetwork.com and osimaging.com, we are scheduled to roll out several new offerings before year's end which we believe will assist us in continuing with our top and bottom line growth."
He added, "With the recent announcement of our email deployment capabilities, we will begin to see a decrease in our marketing expenses based on internal marketing efforts. This will also give us a great growth potential to continue to increase our paid memberships and create revenue streams before we were unable to capture."
About Commerce Planet, Inc.
Commerce Planet, Inc. through its websites 'commerceplanet.com', 'osimaging.com', 'onlinesupplier.com', 'buydiscount.com', 'mysoftwaretutor.com', and 'legacynetwork.com' provides ecommerce solutions, internet marketing, media fulfillment, and thousands of high value products at significant savings to its online loyalty club customers and members.
To find out more about Commerce Planet, Inc. (OTC Bulletin Board: CPNE), visit our website at www.commerceplanet.com. The Company's public financial information and filings can be viewed at www.sec.gov.
Forward Looking Statements
This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products and services or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law.
SOURCE Commerce Planet, Inc.
Michael Hill, Chairman and CEO of Commerce Planet, Inc., +1-805-964-9126, ext. 3134, mhill@commerceplanet.com http://www.prnewswire.com
Copyright (C) 2006 PR Newswire. All rights reserved.
GLIF (0.046) News
Grant Life Sciences enters into Memorandum of Understanding (MOU) with Chinese medical device company to manufacture and distribute Grant's point-of-care, rapid diagnostic tests in China and Hong Kong
9/13/2006
LOS ANGELES, Sep 13, 2006 (BUSINESS WIRE) --
"When finalized, this relationship will fit with Grant's new corporate strategy: to (1) acquire products and technologies via in-licensing activities and optimize these products and technologies; (2) out-license them for further development and sales; and (3) drive sales through our own established marketing channels." -Dr. Hun-Chi Lin, President and Chief Scientist, Grant Life Sciences
Grant Life Sciences Inc. (OTC BB: GLIF) announced today that it has signed a Memorandum of Understanding (MOU) with GuongDong Kangermei Industry Development Co. Ltd. (GDK) to license the manufacturing and distribution rights of Grant's AccuDx line of rapid, point-of-care (POC) tests in China and Hong Kong. Below is a summary of the key terms of the MOU, which will be used as the basis for a definitive License and Collaboration Agreement between Grant and GDK:
-- Grant agrees to license the manufacturing, distribution, and sales rights of certain AccuDx products for the territories of China and Hong Kong to GDK. The AccuDx products include POC tests to detect Hepatitis B and C, HIV 1 and 2, Dengue Fever, and heart attack markers Troponin 1 and Myoglobin.
--Grant agrees to use GDK as an OEM (original equipment manufacturer) to produce AccuDx products for the markets outside of China and Hong Kong for an initial period of four years.
--All products manufactured by GDK that are to be sold outside of China/Hong Kong shall be handled by Grant.
--Grant will own an undisclosed percentage of equity in GDK.
--GDK agrees that Grant will have one Director seat.
--GDK agrees to pay Grant RMB$1.0 million upfront to facilitate technology transfer.
"When this MOU is finalized, we look forward to a long and mutually beneficial relationship between Grant and GDK," said Huok Xin, CEO of GDK.
"When completed, this relationship with GDK will fit with Grant Life Science's new corporate strategy: to (1) acquire new products and technologies through in-licensing activities and optimize these products and technologies; (2) out-license them for further development and sales; and (3) drive sales through our own established marketing channels," said Dr. Hun-Chi Lin, President and Chief Scientist, Grant Life Sciences. "We expect this relationship with GDK will enable Grant to gain access in China to a large consumer market for our technologies and products."
About GDK
GuongDong Kangermei Industry Development Co., Ltd. (GDK) is a medical device company located in GuongDong Province, China, and has established a manufacturing facility and distribution channel in China. GDK is principally involved in the manufacturing of medical instrument sets comprising single-use injection syringes and single-use blood and plasma transfusion sets.
About Grant Life Sciences
Grant Life Sciences Inc., a development stage company, engages in the research, development, marketing, and sale of diagnostic kits for the screening, monitoring, and diagnosis of diseases with emphasis on women's health, infectious diseases, and cancers.
Forward-Looking Safe Harbor Statement
With the exception of historical information, the matters discussed in this press release are "forward-looking statements" that involve a number of risks and uncertainties. The actual future results of Grant Life Sciences could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates and unanticipated events such as terrorist activities, results of clinical trials, and market acceptance of the Company's products. In some cases, "forward-looking statements" can be identified by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," or other comparable terminology. Although Grant Life Sciences believes that the expectations reflected in the "forward-looking" statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such "forward-looking statements" will be achieved. Grant Life Sciences undertakes no duty to update any of the "forward-looking statements," whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such "forward-looking statements." For further risk factors associated with our Company, review our SEC filings.
SOURCE: Grant Life Sciences Inc.
Grant Life Sciences Inc. Don Rutherford, 949-521-1232 CFO
Copyright Business Wire 2006
MDTV (.73) 20 Mio Financing News
MDU Communications Closes $20 Million Financing
9/12/2006
TOTOWA, NEW JERSEY, Sep 12, 2006 (CCNMatthews via COMTEX News Network) --
MDU Communications International, Inc. (OTCBB:MDTV), and its wholly owned subsidiary MDU Communications (USA) Inc., a leading end-to-end provider of DIRECTV(R) digital satellite television programming and broadband Internet services to the United States residential multi-dwelling unit market, today announces that it has closed a $20 million revolving credit financing facility with Full Circle Funding, LP ("Full Circle") and FCC, LLC ("First Capital").
The financing is a five year senior secured revolving credit facility of up to $20 million under which the Company will effectively pay 'interest only' on actual principal drawn during the term of the agreement. The competitive rate of interest decreases as the Company draws upon pre-established levels of the principal. The proceeds will be used to fund the Company's subscriber growth and will provide the Company an alternative to additional equity capital raises. Pursuant to the terms of the agreement, the Company will issue Full Circle and First Capital five-year warrants to collectively purchase an amount of shares equal to approximately two percent of the Company's outstanding number of shares of common stock at an exercise price thirty percent above market on the day the original term sheet was signed. Morgan Joseph & Co. Inc. acted as financial advisor and placement agent for the financing.
"We believe this is an ideal long term non-dilutive financing solution for the funding of our subscriber growth going forward, particularly given the flexibility of the financing and its competitive interest rate, our progress towards achieving positive EBITDA and our established base of subscribers and operations from which we can accelerate growth in the Northeast, Mid-Atlantic, Southeast and Midwest multi-family markets. We remain very impressed with the responsiveness and receptiveness of Full Circle and First Capital in tailoring this facility to accommodate our funding requirements," commented Sheldon Nelson, President and CEO of MDU Communications.
Additional information regarding this credit facility will be provided pursuant to required filings and deadlines established by the Securities and Exchange Commission.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements relating to subscriber and revenue growth of the Company. Such statements involve risks and uncertainties which may cause results to differ materially from those set forth in these statements, including, but not limited to, fluctuations in operating results and operating plans, deployment of new subscribers, closing of certain acquisitions, market forces, supplier negotiations and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's 10-KSB for year ended September 30, 2005, and incorporated herein by reference.
About MDU Communications: MDU Communications International, Inc. (OTCBB:MDTV), through its wholly owned subsidiary MDU Communications (USA) Inc., is a leading full service provider of premium communication/information services, including DIRECTV(R) digital satellite television, private cable television services and high-speed (broadband) Internet access, exclusively to the United States multi-dwelling unit (MDU) marketplace - estimated to include 26 million residences. The Company is committed to delivering state-of-the-art and next generation interactive communication service solutions to MDU property owners and residents. For additional information, please see www.mduc.com or contact Investor Relations.
About Full Circle: Full Circle Finding, LP ("Full Circle Capital"), Stamford, CT, is a specialty finance company formed in September 2005 to originate and acquire senior secured loans, participating debt instruments and leases in niche or underserved markets. One of Full Circle Capital's primary initiatives is to offer flexible borrowing solutions to media and communications companies for the purpose of growth capital and new development, acquisitions and/or refinancing of existing capital. Full Circle Capital manages a captive pool of capital for these purposes.
About First Capital: First Capital has been providing prompt, professional and reliable financing solutions since 1987 across the United States. In 2003, a group of private investors and the management team decided to take First Capital into a new and exciting direction. As a result, First Capital has both the professional staff and the financial strength to serve the needs of middle market businesses throughout the United States. First Capital implemented its new plan, focusing on senior secured revolving credit facilities for clients with financing needs from $35,000 to $250 million. In addition, First Capital can provide its clients with outsourcing solutions to the managing of its accounts receivable and credit default swaps on accounts receivable. As a result of its focus on client service, First Capital has become one of the largest independent full service commercial finance companies in the United States. In addition, First Capital has leveraged its expertise in receivables finance to become a manager of asset portfolios for others and is an active issuer of receivables-backed securities. First Capital is staffed with over 160 experienced and dedicated employees across the country. Responsiveness and service to our clients when they need it most is First Capital's strategic advantage over its competitors.
SOURCE: MDU Communications International, Inc.
MDU Communications International, Inc.
Sheldon Nelson
CEO
(973) 237-9499
investor@mduc.com
www.mduc.com
Full Circle Finding, LP
John Stuart
Managing Partner
(203) 517-4124
info@fcfcapital.com
www.fcfcapital.com
First Capital
Geoffrey Marcus
Managing Director
Toll Free: 1-800-619-0804
web-leads@firstcapital.com
www.firstcapital.com
Copyright (C) 2006 CCNMatthews. All rights reserved.
ABTG now 0.159
ABTG 0.149
ABTG 0.135 watch it
hello waxweazle
greetings
bauspara
VACM watch it
thanks. that means there would be 229 billion preferred shares??? lol
i´ve a question to the board.
what´s the o/s
and would you recieve a dividend for the 10.000 preferred shares.
what can you do with them???
XKEM NEWS
Demand for New Sickle Cell Drug NICOSAN(TM) Far Exceeds Supply; Xechem Nigeria Accelerates Construction of Commercial Scale Production Facility
NEW BRUNSWICK, N.J., Jul 26, 2006 (BUSINESS WIRE) -- Xechem International, Inc. (OTC BB: XKEM) announced today that response to the first limited sales and distribution of NICOSAN(TM), its new product for the prophylactic management of Sickle Cell Disease (SCD), by its subsidiary, Xechem Pharmaceuticals Nigeria, Ltd. (Xechem Nigeria), has been far greater than anticipated. Xechem Nigeria has broken ground for a new state-of-the-art commercial scale production facility and accelerated the facility's construction schedule. Xechem Nigeria, which received regulatory approval for NICOSAN(TM), its first major breakthrough "Natural Herbal Drug," on July 3rd, 2006 from the National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC), has been producing the drug in limited quantities at its pilot scale facility in Abuja, Nigeria.
Xechem Nigeria's new commercial scale facility will have capacity to meet the demand of Nigeria and other African countries. Nigeria alone has 4 million sickle cell disease patients. The new facility will also be able to supply the drug for the clinical trials in the United States and the European Union.
NICOSAN(TM) was launched by the President of Nigeria, His Excellency Chief Olusegun Obasanjo on July 6th, 2006 at SHESTCO Complex. Immediately after the launch ceremony Xechem Nigeria has started direct sales of NICOSAN(TM) in Abuja, the Federal Capital Territory of Nigeria.
The drug is taken through one-a-day capsules which, once started, must be taken daily by the patient. The current price for a months supply for Adults is established at N 3,000 Naira (approx. US $23) and for Pediatrics at N 2,400 Naira (approx. US $18), respectively. Xechem is also accepting mail orders for the drug from other States within Nigeria.
The financing for this first phase of construction was supplied by Nigerian Export-Import (NEXIM) Bank, which loaned Xechem Nigeria N150 Million Naira (US$1.2 million) in June of this year. Xechem estimates that the expanded facility will be fully operational within 9 months.
Dr. Ramesh Pandey, Chairman and CEO of the Xechem Companies said, "This is a very exciting time for Xechem and one that has been more than four years in the making. Getting NICOSAN(TM) approved for the prophylactic management of Sickle Cell Disease (SCD) was a major milestone which changes Xechem from a research and development company to a full scale business venture with NICOSAN(TM) to market.
"This also required the construction of a full scale production facility, on which we have now broken ground This plant will meet all the current Good Manufacturing Practices (cGMP) guidelines, the first facility in Nigeria to do so. We are grateful to NEXIM Bank for the loan and their early support for this project. This will help ensure the completion of our expanded facility in the shortest possible timeframe. Xechem is very proud to be the leader in bringing NICOSAN(TM) for Sickle Cell sufferers first in Nigerian market which will be followed throughout the African continent and the world."
About NICOSAN(TM)
NICOSAN(TM) is an anti-sickling, phyto-pharmaceutical (Natural Herbal Drug) for the prophylactic management of Sickle Cell Disease (SCD). It was developed by Nigerian scientists at the National Institute for Pharmaceutical Research and Development (NIPRD). In clinical studies conducted under NIPRD's auspices, the drug has shown to substantially reduce the degree of sickling of the red blood cells of those afflicted with the disease. While not a cure, the clinical trials have confirmed that the large majority of patients taking NICOSAN(TM) no longer experience sickle cell "crises" while on the medication, and even among those whose crises are not eliminated, the number and severity of the crises are substantially reduced. Preliminary studies carried out at the National Heart, Lung and Blood Institute Sickle Cell Disease Reference Laboratory (NHLBI-SCDRL), NIH, at the Children's Hospital of Philadelphia (CHOP) and Xechem Research Laboratory in New Brunswick, NJ have confirmed some of the Nigerian studies.
About Sickle Cell Disease
Sickle Cell Disease (SCD) is an inherited blood disorder caused by an abnormality in the hemoglobin molecule. Patients with the disease often produce stiff, abnormally shaped red blood cells that often do not flow freely through the blood vessels. This can create clogs in the vessels, which in turn cut off the flow of normal hemoglobin and oxygen to parts of the body, and can cause severe painful attacks or "crises", damage to various organs and shortened life spans. People with SCD often suffer unpredictable painful crises several times a year lasting from a few hours to a week or more. In the US, there are approximately 80,000 patients with SCD. In Nigeria, that number is believed to be approximately 4 million, and worldwide at least 12 million individuals are afflicted with SCD.
About Xechem
Xechem International is a development stage biopharmaceutical company working on anticancer, antiviral (including AIDS), antifungal, antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Its focus is on the development of phyto-pharmaceuticals (natural herbal drugs) and other proprietary technologies, including those used in the treatment of orphan diseases. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its recent focus and resources have been directed primarily toward the development and launch of NICOSAN(TM) (to be marketed as HEMOXIN(TM) in the US and Europe). With the Nigerian regulatory approval now in hand, Xechem has turned to the commercialization of the drug in Nigeria and plans also to pursue US FDA and European regulatory approval. In addition to NICOSAN(TM), Xechem is also working on another sickle cell compound, 5-HMF, which it has licensed from Virginia Commonwealth University.
Forward Looking Statements
This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks and uncertainties.
SOURCE: Xechem International, Inc.
CONTACT: Xechem International, Inc.
Stephen Burg, 707-425-8855
Copyright Business Wire 2006
hello guys!
i´m in with 250.000 shares since now
what´s up here and what are you expecting for tomorrow?